Moderna and Merck Develop Vaccine Cutting Risks of Skin Cancer

Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

More In Science

How Breast Cancer Treatment Has Advanced

Breast cancer treatment advancements.

FDA Warns Some Eyedrops From CVS, Rite Aid and Others Carry Possible Infection Risk

U.S. health regulators are warning consumers not to use more than two dozen varieties of over-the-counter eyedrops because of the risk of infections that could lead to blindness.

Your Monday Weather Forecast for October 30, 2023

Cheddar News checks in with your coast-to-coast weather forecast for Monday, Oct. 30, 2023.

Be Well: The Amazing Band Workout

Resistance band workouts.

Be Well: Author Clea Shearer on Determination to Beat Breast Cancer

Clea Shearer talks breast cancer battle.

Be Well: Breast Cancer Diagnoses and Mental Health

Understanding mental health implications of a breast cancer diagnosis.

Study Shows Fish Diet Reduces Heart Disease Risk

A new study finds eating more fish could help mitigate heart disease risk.

Your Monday Weather Forecast for Oct. 30, 2023

Cheddar News checks in with your coast-to-coast weather forecast for Monday, Oct. 30, 2023.

Your Weekend Weather Forecast

Your Weekend Weather Forecast

Study: Pigeons Problem Solve Like A.I.

A study published in the Journal I Science suggests pigeons can solve problems.

Load More